Urolithin A for Walking Speed & Mobility

Reviewed by SOMA HEALTH's Medical Research Team

How fast you walk when you are not thinking about it turns out to be one of the most informative simple measurements in aging research. Because urolithin A is studied for the muscle energy systems that power movement, people ask whether it can support the everyday mobility that gait speed reflects. Here is an evidence-first look, with the limits stated plainly.

Why walking speed is such a useful marker

Researchers sometimes call usual gait speed a sixth vital sign. The reason is that a short, ordinary walk pulls together an enormous amount of physiology: leg strength, balance, cardiovascular fitness, joint function, coordination, and the energy supply that keeps muscles working. A widely cited pooled analysis led by Studenski (JAMA, 2011) reported that usual walking speed in older adults tracked with survival, which is why clinicians began treating it as a convenient summary of overall functional health rather than just a measure of how quickly someone crosses a room.

Comfortable walking pace tends to slow gradually with age as muscle mass, strength, and aerobic capacity change. That slowing is not fixed. It responds to activity, strength work, and general health. The interesting scientific question is whether supporting the cellular energy machinery inside muscle could complement the movement and training that keep people mobile.

The muscle-energy rationale for urolithin A

Urolithin A is a gut postbiotic. Your microbiome can make it from ellagitannins, the polyphenols in pomegranate, walnuts, and some berries, but only certain people carry the bacteria that produce meaningful amounts, which is why a standardized dose is studied instead of relying on diet.

Its central action is support for mitophagy, the recycling of worn-out mitochondria so cells can keep a fresher, more efficient population of these energy producers. Walking, climbing stairs, and rising from a chair are all sustained, energy-hungry tasks, and skeletal muscle is one of the most mitochondria-dense tissues in the body. The logic, then, is that by supporting mitochondrial quality, urolithin A may support the cellular energy that underlies muscle endurance and everyday function. That is a mechanism worth understanding, and it is distinct from a claim that a supplement will make you walk faster.

What the human trials actually found

Proven in people: safety and mitochondrial engagement

The first-in-human study, Andreux and colleagues in Nature Metabolism (2019), found urolithin A safe and well tolerated up to 1,000 mg per day, with a mitochondrial gene-expression signature appearing in muscle. This is the bedrock: the compound is well tolerated and it engages the intended pathway in people.

Newer human trials: endurance and muscle function

The most relevant results for mobility come from muscle-function trials. Liu, D'Amico and colleagues (JAMA Network Open, 2022) studied older adults over roughly four months and reported improvements in muscle endurance, the capacity to keep a muscle working, which is closely tied to sustained activities like walking. Singh and colleagues (Cell Reports Medicine, 2022) tested 500 mg and 1,000 mg daily for four months in middle-aged adults and reported improvements in muscle strength and aspects of exercise performance. A 2024 randomized trial in resistance-trained men (Journal of the International Society of Sports Nutrition) and a 2025 trial in distance runners extended the work into fitter and endurance-focused populations.

The candid limitation: these trials measured muscle strength, endurance and exercise performance, not usual gait speed or a timed walk as the primary endpoint. So the accurate statement is that human evidence supports muscle endurance and strength, which are components of mobility, while a direct effect on your walking speed is a plausible extension rather than a demonstrated finding. A 2024 systematic review in Ageing Research Reviews summarized the overall human picture as promising but still emerging, which is exactly how we frame it.

Preclinical research: where the muscle interest began

The animal and cell work explains why muscle and function became the focus. Ryu and colleagues (Nature Medicine, 2016, preclinical) showed that urolithin A induced mitophagy, improved muscle function in rodents, and extended lifespan in the worm C. elegans. D'Amico and colleagues (Aging Cell, 2022, preclinical) examined joint and cartilage outcomes in osteoarthritis models, which is relevant context for mobility since joints and muscle both contribute to how we move. These are laboratory findings in animals and cells. They are valuable for understanding mechanism and they do not establish what will happen to a person's mobility.

Using it sensibly for mobility

The strongest, best-established levers for walking speed and everyday mobility are movement itself: regular walking, lower-body strength work, balance practice, and enough protein and sleep to support recovery. Those do the heavy lifting. Urolithin A is best understood as a daily foundation for mitochondrial health that may support the muscle energy systems mobility depends on, layered on top of an active routine rather than substituting for it.

Consistency mirrors the evidence, which came from daily dosing over eight to sixteen weeks, so think in months and set expectations at the level of supporting healthy muscle function, not transforming a timed walk. A meaningful, unexplained slowing of your gait, new balance problems, pain with walking, or frequent stumbles are reasons to be evaluated. This guide is educational and is not a treatment for any condition, so please see a qualified healthcare provider about any mobility or balance concern.

For the full background on the compound and the evidence, read our urolithin A guide and compare options in our best urolithin A gummies roundup.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.